cyclosporine has been researched along with Diabetic Angiopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agardh, CD; Agardh, E; Fredrikson, GN; Gomez, MF; González Bosc, LV; Hultgårdh-Nilsson, A; Nilsson, J; Nilsson-Berglund, LM; Nilsson-Ohman, J; Salehi, A; Sigvardsson, M; Smith, ML; Wamhoff, BR; Zetterqvist, AV | 1 |
1 other study(ies) available for cyclosporine and Diabetic Angiopathies
| Article | Year |
|---|---|
Nuclear factor of activated T cells regulates osteopontin expression in arterial smooth muscle in response to diabetes-induced hyperglycemia.
Topics: Animals; Apyrase; Arteries; Binding Sites; Blood Glucose; Calcineurin; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Disease Models, Animal; Enzyme Inhibitors; Female; Glucose Tolerance Test; Humans; Hyperglycemia; Jurkat Cells; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; NFATC Transcription Factors; Osteopontin; Promoter Regions, Genetic; Pyrazoles; RNA, Messenger; Signal Transduction; Time Factors; Transcriptional Activation; Transfection; Uridine Triphosphate | 2010 |